AGP Executive Report
Last update: 10 hours agoActivist Pressure on AIM Tech: Bernstein is pushing Porvair’s board to explore strategic alternatives, pointing to a “substantially below” valuation and highlighting shareholder frustration (24% voting against the chairman). Clinical Pipeline Update: Avacta says its preCISION platform is advancing—AVA6103 entered clinic in March 2026 and AVA6000 continues Phase 1b enrolment, while dose limits shifted after cardiac-safety discussions. Crypto Participation: A Fed survey finds 10% of U.S. adults used or held crypto in 2025 (up from 7% in 2024), with most holding it as an investment. Ukraine Reconstruction Pitch: Zelenskyy and adviser Oksana Markarova discussed partner work on economic and investment priorities, including defense technology, ahead of a June recovery conference in Gdansk. Investor-Litigation Wave: New class-action filings keep rolling in—Sportradar, Commvault, and multiple others—adding fresh deadlines for shareholders. Big Ticket Capex: TELUS plans $66B+ in Canada through 2030 to expand connectivity and AI infrastructure.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.